approval · primary record
TRASTUZUMAB-DKST
FDA · BLA · 2024-11-13
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2024-11-13 |
| Brand | OGIVRI |
| Sponsor | MYLAN GMBH |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T10:39:27.313Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:TRASTUZUMAB-DKST:2024-11-13
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Trastuzumab-Dkst · compound